Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Periprocedural Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention Following Fibrinolysis for ST-Segment Elevation Myocardial Infarction.

Rashid MK, Singh K, Bernick J, Wells GA, Hibbert B, Russo J, So DY, Le May MR; CAPITAL PCI Group.

J Invasive Cardiol. 2019 Dec;31(12):E387-E391.

2.

The Use and Misuse of Brave New World in the CRISPR Debate.

So D.

CRISPR J. 2019 Oct;2(5):316-323. doi: 10.1089/crispr.2019.0046.

PMID:
31599683
3.

Same-Day Discharge After Elective Percutaneous Coronary Interventions in Ontario, Canada.

Madan M, Bagai A, Overgaard CB, Fang J, Koh M, Cantor WJ, Garg P, Natarajan MK, So DYF, Ko DT.

J Am Heart Assoc. 2019 Jul 2;8(13):e012131. doi: 10.1161/JAHA.119.012131. Epub 2019 Jun 24.

4.

Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review.

Elliott J, Kelly SE, Bai Z, Liu W, Skidmore B, Boucher M, So DYF, Wells GA.

Can J Cardiol. 2019 Aug;35(8):1039-1046. doi: 10.1016/j.cjca.2019.01.021. Epub 2019 Feb 6. Review.

PMID:
31376905
5.

Production and faecal fermentation of pentose oligomers of hemicellulose: Study of variables influencing bioprocess efficiency.

Singh RD, So D, Yao CK, Gill P, Pillai N, Muir J, Arora A.

Food Chem. 2019 Nov 1;297:124945. doi: 10.1016/j.foodchem.2019.06.012. Epub 2019 Jun 5.

PMID:
31253310
6.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].

Wells GA, Elliott J, Kelly S, Bai Z, Boucher M, Skidmore B, So D, Laplante S, Lee K.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.

7.

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review.

Elliott J, Kelly SE, Bai Z, Skidmore B, Boucher M, So DYF, Wells GA.

BMJ Open. 2019 Jun 16;9(6):e022271. doi: 10.1136/bmjopen-2018-022271.

8.

Native coronary disease progression post coronary artery bypass grafting.

Jabagi H, Chong AY, So D, Glineur D, Rubens FD.

Cardiovasc Revasc Med. 2019 May 24. pii: S1553-8389(19)30316-1. doi: 10.1016/j.carrev.2019.05.017. [Epub ahead of print]

PMID:
31204241
9.

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12. Review.

PMID:
31202949
10.

Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial.

Glineur D, Grau JB, Etienne PY, Benedetto U, Fortier JH, Papadatos S, Laruelle C, Pieters D, El Khoury E, Blouard P, Timmermans P, Ruel M, Chong AY, So D, Chan V, Rubens F, Gaudino MF.

Eur Heart J. 2019 Aug 1;40(29):2421-2428. doi: 10.1093/eurheartj/ehz329.

PMID:
31155673
11.

Clopidogrel Pharmacogenetics.

Pereira NL, Rihal CS, So DYF, Rosenberg Y, Lennon RJ, Mathew V, Goodman SG, Weinshilboum RM, Wang L, Baudhuin LM, Lerman A, Hasan A, Iturriaga E, Fu YP, Geller N, Bailey K, Farkouh ME.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007811. doi: 10.1161/CIRCINTERVENTIONS.119.007811.

PMID:
30998396
12.

Evaluation of an in vitro coronary stent thrombosis model for preclinical assessment.

Perry-Nguyen D, Jung RG, Labinaz A, Duchez AC, Dewidar O, Simard T, Karunakaran D, Majeed K, Sarathy K, Li R, Ramirez FD, Di Santo P, Rochman R, So D, Foin N, Hibbert B.

Platelets. 2019 Apr 11:1-7. doi: 10.1080/09537104.2019.1595564. [Epub ahead of print]

PMID:
30973035
13.

Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation.

Ngan AWL, Grace Tsui M, So DHF, Leung WY, Chan DW, Yao KM.

Front Oncol. 2019 Mar 19;9:154. doi: 10.3389/fonc.2019.00154. eCollection 2019.

14.

Activity-Regulated Cytoskeleton-Associated Protein (Arc/Arg3.1) is Transiently Expressed after Heat Shock Stress and Suppresses Heat Shock Factor 1.

Park AY, Park YS, So D, Song IK, Choi JE, Kim HJ, Lee KJ.

Sci Rep. 2019 Feb 22;9(1):2592. doi: 10.1038/s41598-019-39292-1.

15.

Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.

Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, Visintini S, Simard T, Di Santo P, Mathew R, So DY, Takeda K, Garan AR, Karmpaliotis D, Takayama H, Kirtane AJ, Hibbert B.

J Am Coll Cardiol. 2019 Feb 19;73(6):654-662. doi: 10.1016/j.jacc.2018.10.085.

16.

International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing.

Pereira NL, So D, Bae JH, Chavez I, Jeong MH, Kim SW, Madan M, Graham J, O'Cochlain F, Pauley N, Lennon RJ, Bailey K, Hasan A, Baudhuin LM, Bell MR, Lerman A, Goodman S, Mathew V, Farkouh M, Rihal CS.

Pharmacogenet Genomics. 2019 Jun;29(4):76-83. doi: 10.1097/FPC.0000000000000368.

PMID:
30724853
17.

Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes.

Saw J, Starovoytov A, Humphries K, Sheth T, So D, Minhas K, Brass N, Lavoie A, Bishop H, Lavi S, Pearce C, Renner S, Madan M, Welsh RC, Lutchmedial S, Vijayaraghavan R, Aymong E, Har B, Ibrahim R, Gornik HL, Ganesh S, Buller C, Matteau A, Martucci G, Ko D, Mancini GBJ.

Eur Heart J. 2019 Apr 14;40(15):1188-1197. doi: 10.1093/eurheartj/ehz007.

PMID:
30698711
18.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Review of the Clinical Impact of Treatment Duration [Internet].

Wells GA, Elliott J, Kelly S, So D, Boucher M, Bai Z, Liu W, Skidmore B.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug.

19.

In-hospital outcomes of STEMI patients on warfarin undergoing primary PCI.

Marbach JA, Almufleh A, Bernick J, Blondeau M, Osborne C, Russo J, Hibbert B, Froeschl M, Labinaz M, Glover C, Dick A, So D, Chong AY, Le May M.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):41-47. doi: 10.1002/ccd.27720. Epub 2018 Sep 30.

PMID:
30269392
20.

Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease.

Rakic S, Hung YMA, Smith M, So D, Tayler HM, Varney W, Wild J, Harris S, Holmes C, Love S, Stewart W, Nicoll JAR, Boche D.

Acta Neuropathol Commun. 2018 Sep 7;6(1):88. doi: 10.1186/s40478-018-0592-3.

21.

H2 Receptor Antagonists versus Proton Pump Inhibitors in Patients on Dual Antiplatelet Therapy for Coronary Artery Disease: A Systematic Review.

Almufleh A, Ramirez FD, So D, Le May M, Chong AY, Torabi N, Hibbert B.

Cardiology. 2018;140(2):115-123. doi: 10.1159/000489165. Epub 2018 Jul 2.

22.

Classification of crystallization outcomes using deep convolutional neural networks.

Bruno AE, Charbonneau P, Newman J, Snell EH, So DR, Vanhoucke V, Watkins CJ, Williams S, Wilson J.

PLoS One. 2018 Jun 20;13(6):e0198883. doi: 10.1371/journal.pone.0198883. eCollection 2018.

23.

Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense.

So D, Shin HW, Kim J, Lee M, Myeong J, Chun YS, Park JW.

Oncogene. 2018 Sep;37(38):5191-5204. doi: 10.1038/s41388-018-0339-4. Epub 2018 May 29.

PMID:
29844574
24.

Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis.

So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL.

Am J Clin Nutr. 2018 Jun 1;107(6):965-983. doi: 10.1093/ajcn/nqy041.

PMID:
29757343
25.

PU-Graphene Oxide Composite; Effect of Various Chain Extender on Properties.

Choi S, Park S, So D, Huh H.

J Nanosci Nanotechnol. 2017 Apr;17(4):2541-544.

PMID:
29652122
26.

Photoplethysmography using a smartphone application for assessment of ulnar artery patency: a randomized clinical trial.

Di Santo P, Harnett DT, Simard T, Ramirez FD, Pourdjabbar A, Yousef A, Moreland R, Bernick J, Wells G, Dick A, Le May M, Labinaz M, So D, Motazedian P, Jung RG, Chandrasekhar J, Mehran R, Chong AY, Hibbert B.

CMAJ. 2018 Apr 3;190(13):E380-E388. doi: 10.1503/cmaj.170432.

27.

PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.

Chih S, Chong AY, Erthal F, deKemp RA, Davies RA, Stadnick E, So DY, Overgaard C, Wells G, Mielniczuk LM, Beanlands RSB.

J Am Coll Cardiol. 2018 Apr 3;71(13):1444-1456. doi: 10.1016/j.jacc.2018.01.062.

28.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel.

Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19. Review.

PMID:
29475527
29.

Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery.

Russo JJ, James TE, Ruel M, Dupuis JY, Singh K, Goubran D, Malhotra N, Rubens F, Chong AY, Hibbert B, Boland P, Tran DT, Tanguay JF, Lordkipanidzé M, Perrault L, Wells GA, Bourke M, Chan V, So DY; CArdiovascular Percutaneous Intervention TriAL (CAPITAL) investigators.

Eur Heart J Acute Cardiovasc Care. 2018 Jan 1:2048872617740832. doi: 10.1177/2048872617740832. [Epub ahead of print]

PMID:
29313713
30.

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.

Angiolillo DJ, Rollini F, Storey RF, Bhatt DL, James S, Schneider DJ, Sibbing D, So DYF, Trenk D, Alexopoulos D, Gurbel PA, Hochholzer W, De Luca L, Bonello L, Aradi D, Cuisset T, Tantry US, Wang TY, Valgimigli M, Waksman R, Mehran R, Montalescot G, Franchi F, Price MJ.

Circulation. 2017 Nov 14;136(20):1955-1975. doi: 10.1161/CIRCULATIONAHA.117.031164. Epub 2017 Oct 30. Review.

PMID:
29084738
31.

Accelerated tumor growth under intermittent hypoxia is associated with hypoxia-inducible factor-1-dependent adaptive responses to hypoxia.

Yoon DW, So D, Min S, Kim J, Lee M, Khalmuratova R, Cho CH, Park JW, Shin HW.

Oncotarget. 2017 Jun 27;8(37):61592-61603. doi: 10.18632/oncotarget.18644. eCollection 2017 Sep 22.

32.

Ethics approval in applications for open-access clinical trial data: An analysis of researcher statements to clinicalstudydatarequest.com.

So D, Knoppers BM.

PLoS One. 2017 Sep 8;12(9):e0184491. doi: 10.1371/journal.pone.0184491. eCollection 2017.

33.

Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).

Singh K, Rashid M, So DY, Glover CA, Froeschl M, Hibbert B, Chong AY, Dick A, Labinaz M, Le May M.

Catheter Cardiovasc Interv. 2018 Apr 1;91(5):842-848. doi: 10.1002/ccd.27215. Epub 2017 Jul 22.

PMID:
28733995
34.

P2Y12 receptor inhibitor resistance and coronary artery disease: a bench to bedside primer for cardiovascular specialists.

So DYF, Bagai A, Tran U, Verma S, Mehta SR.

Curr Opin Cardiol. 2017 Sep;32(5):617-626. doi: 10.1097/HCO.0000000000000440. Review.

PMID:
28661903
36.

Disease Resistance and the Definition of Genetic Enhancement.

So D, Kleiderman E, Touré SB, Joly Y.

Front Genet. 2017 Apr 10;8:40. doi: 10.3389/fgene.2017.00040. eCollection 2017.

37.

Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review.

Elliott J, Kelly SE, Bai Z, Liu W, Skidmore B, Boucher M, So DY, Wells GA.

BMJ Open. 2017 Apr 4;7(4):e015421. doi: 10.1136/bmjopen-2016-015421. Review.

38.

Impact of mean arterial pressure on clinical outcomes in comatose survivors of out-of-hospital cardiac arrest: Insights from the University of Ottawa Heart Institute Regional Cardiac Arrest Registry (CAPITAL-CARe).

Russo JJ, James TE, Hibbert B, Yousef A, Osborne C, Wells GA, Froeschl MP, So DY, Chong AY, Labinaz M, Glover CA, Marquis JF, Dick A, Bernick J, Le May MR.

Resuscitation. 2017 Apr;113:27-32. doi: 10.1016/j.resuscitation.2017.01.007. Epub 2017 Jan 18.

PMID:
28109998
39.

A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study.

Pourdjabbar A, Hibbert B, Chong AY, Le May MR, Labinaz M, Simard T, Ramirez FD, Lugomirski P, Maze R, Froeschl M, Glover C, Dick A, Marquis JF, Bernick J, Wells G, So DY; CAPITAL Investigators.

Thromb Haemost. 2017 Jan 26;117(2):303-310. doi: 10.1160/TH16-04-0340. Epub 2016 Oct 20.

PMID:
27761582
40.

Solid-state colloidal CuInS2 quantum dot solar cells enabled by bulk heterojunctions.

So D, Pradhan S, Konstantatos G.

Nanoscale. 2016 Sep 22;8(37):16776-16785.

PMID:
27714085
41.

Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.

Rashid MK, Guron N, Bernick J, Wells GA, Blondeau M, Chong AY, Dick A, Froeschl MP, Glover CA, Hibbert B, Labinaz M, Marquis JF, Osborne C, So DY, Le May MR.

JACC Cardiovasc Interv. 2016 Oct 10;9(19):2014-2020. doi: 10.1016/j.jcin.2016.07.004.

42.

Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome.

Pelletier R, Choi J, Winters N, Eisenberg MJ, Bacon SL, Cox J, Daskalopoulou SS, Lavoie KL, Karp I, Shimony A, So D, Thanassoulis G, Pilote L; GENESIS-PRAXY Investigators.

Can J Cardiol. 2016 Dec;32(12):1447-1453. doi: 10.1016/j.cjca.2016.05.018. Epub 2016 Sep 26.

PMID:
27683172
43.

Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib.

Jeong YJ, Kang JS, Lee SI, So DM, Yun J, Baek JY, Kim SK, Lee K, Park SK.

Oncol Lett. 2016 Sep;12(3):2153-2158. Epub 2016 Jul 13.

44.

Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality?

Singh K, Hibbert B, Singh B, Carson K, Premaratne M, Le May M, Chong AY, Arstall M, So D.

Eur Heart J Cardiovasc Pharmacother. 2015 Oct;1(4):220-8. doi: 10.1093/ehjcvp/pvv023. Epub 2015 Apr 29. Review. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):217.

PMID:
27532445
45.

The Fate of Revision Total Knee Arthroplasty With Preoperative Abnormalities in Either Sedimentation Rate or C-Reactive Protein.

Hardcastle JM, So DH, Lee GC.

J Arthroplasty. 2016 Dec;31(12):2831-2834. doi: 10.1016/j.arth.2016.05.044. Epub 2016 Jul 5.

PMID:
27498389
46.

Epigenetics ELSI: Darker Than You Think?

Joly Y, So D, Saulnier K, Dyke SOM.

Trends Genet. 2016 Oct;32(10):591-592. doi: 10.1016/j.tig.2016.07.001. Epub 2016 Jul 22.

PMID:
27460649
47.

Preparation of Graphene Encapsulated Silicon Nanoball.

Kim H, So D, Park S, Huh H.

J Nanosci Nanotechnol. 2016 Feb;16(2):1756-60.

PMID:
27433665
48.

Platelet function testing as a biomarker for efficacy of antiplatelet drugs.

Lordkipanidzé M, So D, Tanguay JF.

Biomark Med. 2016 Aug;10(8):903-18. doi: 10.2217/bmm-2016-0070. Epub 2016 Jul 14. Review.

PMID:
27414976
49.

Impact of Center Experience on Patient Radiation Exposure During Transradial Coronary Angiography and Percutaneous Intervention: A Patient-Level, International, Collaborative, Multi-Center Analysis.

Simard T, Hibbert B, Natarajan MK, Mercuri M, Hetherington SL, Wright R, Delewi R, Piek JJ, Lehmann R, Ruzsa Z, Lange HW, Geijer H, Sandborg M, Kansal V, Bernick J, Di Santo P, Pourdjabbar A, Ramirez FD, Chow BJ, Chong AY, Labinaz M, Le May MR, O'Brien ER, Wells GA, So D.

J Am Heart Assoc. 2016 May 31;5(6). pii: e003333. doi: 10.1161/JAHA.116.003333.

50.

Reply: The Conundrum of Allen's Test Before Transradial Access: To Do or Not to Do?

Singh K, Chong AY, So DY.

JACC Cardiovasc Interv. 2016 May 9;9(9):981. doi: 10.1016/j.jcin.2016.02.043. No abstract available.

Supplemental Content

Support Center